
### [MONDO:0018964](http://purl.obolibrary.org/obo/MONDO_0018964)
**Label:** homocystinuria without methylmalonic aciduria

**Subclasses:** [MONDO:0009609](http://purl.obolibrary.org/obo/MONDO_0009609) (methylcobalamin deficiency type cblG), [MONDO:0017683](http://purl.obolibrary.org/obo/MONDO_0017683) (methylcobalamin deficiency type cblDv1), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0009354](http://purl.obolibrary.org/obo/MONDO_0009354) (methylcobalamin deficiency type cblE), [MONDO:0017685](http://purl.obolibrary.org/obo/MONDO_0017685) (vitamin B12-responsive methylmalonic acidemia, type cblDv2), 

**Corr. equiv. classes:** [Orphanet:2169](http://www.orpha.net/ORDO/Orphanet_2169), [OMIM:236270](http://purl.obolibrary.org/obo/OMIM_236270), [Orphanet:308380](http://www.orpha.net/ORDO/Orphanet_308380), [OMIM:250940](http://purl.obolibrary.org/obo/OMIM_250940), [Orphanet:79283](http://www.orpha.net/ORDO/Orphanet_79283), [Orphanet:308442](http://www.orpha.net/ORDO/Orphanet_308442), [Orphanet:2170](http://www.orpha.net/ORDO/Orphanet_2170), [OMIM:277410](http://purl.obolibrary.org/obo/OMIM_277410), 

**Class expressions from DL-Learner:**

- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 69.72%
- [HP:0001249](http://purl.obolibrary.org/obo/HP_0001249) (Intellectual disability) and [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) 69.72%
- [HP:0000639](http://purl.obolibrary.org/obo/HP_0000639) (Nystagmus) and [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) 69.72%
- [HP:0000496](http://purl.obolibrary.org/obo/HP_0000496) (Abnormality of eye movement) and [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012444](http://purl.obolibrary.org/obo/HP_0012444) (Brain atrophy) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) and [HP:0012547](http://purl.obolibrary.org/obo/HP_0012547) (Abnormal involuntary eye movements) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 69.72%
- [HP:0003223](http://purl.obolibrary.org/obo/HP_0003223) (Decreased methylcobalamin) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 69.72%


